$MNKD Headlines 7 gut checks before the stock market's

New Post Public Reply Private Reply Replies (0) Message Board

Jan 15, 2014 at 1:38 PM

$MNKD Headlines

7 gut checks before the stock market's opening bell 5:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 10:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 12:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 7:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 9:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Hot stocks to watch 6:39 a.m. Sept. 4, 2012 - MarketWatch.com
MannKind in development pact valued up to $130M 6:02 a.m. April 30, 2012 - MarketWatch.com
Stocks to watch Thursday: Diamond Foods, Six Flags 6:59 a.m. Feb. 9, 2012 - MarketWatch
Friday’s biggest gaining & declining stocks 4:48 p.m. Feb. 3, 2012 - Kate Gibson
MannKind prices units offering at 2.8% discount 12:00 p.m. Feb. 3, 2012 - MarketWatch.com
Mannkind sinks 14% on public offering 11:47 a.m. Jan. 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining & declining stocks 4:28 p.m. Aug. 12, 2011 - Sue Chang
Tuesday’s biggest gaining and declining stocks 3:23 p.m. May 10, 2011 - Kate Gibson
BioMimetic, InterMune drop in afternoon trading 1:59 p.m. May 10, 2011 - Val Brickates Kennedy
Tenet, Community Health fall after hours 6:04 p.m. May 9, 2011 - Carla Mozee
Stocks to watch Tuesday: Disney, McDermott 5:34 p.m. May 9, 2011 - Wallace Witkowski
MannKind awaiting more details from FDA on Afrezza 4:33 p.m. May 9, 2011 - Sue Chang
Depomed slides as drug stocks fall; Mannkind soars 11:36 a.m. Feb. 15, 2011 - Val Brickates Kennedy

J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Today - TheStreet.com
Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog 9:31 a.m. Today - Zacks.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Today - InvestorPlace.com
A Step Back for MannKind? 11:00 a.m. Jan. 14, 2014 - Barrons.com
MannKind Slips on Afrezza Update - Analyst Blog 1:22 p.m. Jan. 13, 2014 - Zacks.com
The Next Home Run In Healthcare 9:49 a.m. Jan. 13, 2014 - Seeking Alpha
MannKind's Day Of Reckoning Is Getting Very Close 9:33 a.m. Jan. 13, 2014 - Seeking Alpha
Stocks You Wish You Owned on Thursday 10:36 p.m. Jan. 10, 2014 - WallStreetSectorSelector
Afrezza may miss PDUFA date: Cowen, Piper 3:38 p.m. Jan. 10, 2014 - Seeking Alpha
Mid-Afternoon Market Update: Plug Rises on Secondary Pricing as Markets Remain Mixed Following Jobs Number 2:51 p.m. Jan. 10, 2014 - benzinga.com
Volatility and Options in MannKind Shaking Speculators Out 2:06 p.m. Jan. 10, 2014 - 247WallSt.com
How I Think About MannKind's Afrezza FDA Panel 11:37 a.m. Jan. 10, 2014 - TheStreet.com
Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; Sears Shares Slip 11:27 a.m. Jan. 10, 2014 - benzinga.com
Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss Estimates 10:04 a.m. Jan. 10, 2014 - benzinga.com
MannKind Corp. (MNKD) Surges: Stock Moves 18.4% Higher - Tale of the Tape 9:21 a.m. Jan. 10, 2014 - Zacks.com
MannKind announces Ad Com date, shares stumble 9:08 a.m. Jan. 10, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire 8:33 a.m. Jan. 10, 2014 - 247WallSt.com
Buyout Picks In Healthcare For 2014 7:05 a.m. Jan. 10, 2014 - Seeking Alpha
MannKind Announces Tentative Date of April 1, 2014 for FDA Advisory Committee Review of AFREZZA 5:01 a.m. Jan. 10, 2014 - benzinga.com

MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA 6:00 a.m. Jan. 10, 2014 - GlobeNewswire
MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference 5:00 p.m. Jan. 8, 2014 - GlobeNewswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune 8:00 a.m. Dec. 2, 2013 - PR Newswire
MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare Conference 5:00 p.m. Nov. 27, 2013 - BusinessWire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
MannKind Corporation to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 5:00 p.m. Nov. 7, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
MannKind Corporation Reports 2013 Third Quarter Financial Results 9:00 a.m. Nov. 4, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 12:30 p.m. Nov. 1, 2013 - PR Newswire
MannKind Announces FDA Acknowledgement of Resubmission of New Drug Application for AFREZZA 5:00 a.m. Oct. 30, 2013 - BusinessWire
MannKind Corporation to Hold 2013 Third Quarter Financial Results Conference Call on November 4, 2013 1:12 p.m. Oct. 28, 2013 - BusinessWire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 7:00 a.m. Oct. 21, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE
MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for the Treatment of Adults with Diabetes 5:00 a.m. Oct. 14, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...